Fully Online Care
In-House RxDose Adjustments By Provider
Prescription IncludedYes
Telehealth IncludedYes
Online-Only OptionYes
Skip LabsNot Disclosed
- Flat-rate pricing · Discounts available
- No commitment required · Manual refills · Cancel anytime
- 100% online · Free consultation
- Free expedited shipping · Discreet packaging
- Zepbound, Mounjaro, Ozempic, Wegovy, Rybelsus, Foundayo
- Available in all 50 states
- Video consultation required
- Pharmacy data not disclosed
Provider Plans
Zepbound Pen
TirzepatideMonthlyBrand
$299/avg
PharmacyEli Lilly
AdditivesNone
PreservativeNone
BUD (Shelf Life)24 Months
BillingMonthly
CommitmentNo Commitment
Other FeesNo Extra Fees
Auto-RenewsNo
| DoseYour Supply | Your Price | Your Supply | Avg/mo | Your Value |
|---|---|---|---|---|
| 2.5mg/wk10mg/mo | $299.00 | 10mg | 299 | $29.90/mg |
States Excluded From PlanNone
Mounjaro Pen
TirzepatideMonthlyBrand
$499/avg
PharmacyEli Lilly
AdditivesNone
PreservativeNone
BUD (Shelf Life)24 Months
BillingMonthly
CommitmentNo Commitment
Other FeesNo Extra Fees
Auto-RenewsNo
| DoseYour Supply | Your Price | Your Supply | Avg/mo | Your Value |
|---|---|---|---|---|
| 2.5mg/wk10mg/mo | $499.00 | 10mg | 499 | $49.90/mg |
| 5.0mg/wk20mg/mo | $499.00 | 20mg | 499 | $24.95/mg |
| 7.5mg/wk30mg/mo | $499.00 | 30mg | 499 | $16.63/mg |
| 10.0mg/wk40mg/mo | $499.00 | 40mg | 499 | $12.47/mg |
| 12.5mg/wk50mg/mo | $499.00 | 50mg | 499 | $9.98/mg |
| 15.0mg/wk60mg/mo | $499.00 | 60mg | 499 | $8.32/mg |
States Excluded From PlanNone
Provider Details
Self-Pay · HSA / FSA Eligible
CreditSezzleSaleSale: $100 Off
Insurance AcceptedNo
HSA/FSA AcceptedYes
Financing AvailableYes
SaleYes
LegitScript Certified
250,000+ Patients
LegitScript CertifiedYes
HIPAA CompliantYes
Free Express Shipping
Cold-Packed
Free ShippingYes
Expedited ShippingYes
Discreet PackagingYes
Tirz + Sema
Brands: Foundayo Pill · Ozempic Pen · +5
Offers TirzepatideYes
Offers SemaglutideYes
Offers BrandYes
Other TreatmentsYes
Contact & Support
Live ChatDaily 9 AM-10 PM
Provider Notes
Compliance
The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.
General
Zepbound and Foundayo follow LillyDirect's published self-pay pricing.